e-ISSN: Pending
Negative / Null Result ReportOpen access

Is there any role for the Hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?

Botta, Angela; De Carolis, S; Botta, A.; di Pasquo, E.; Del Sordo, Gelsomina; De Carolis, Maria Pia; Lanzone, Antonio; De Carolis, M. P. · 2015

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

The finding, in one line

Additional treatments with steroids, plasma exchanges and immunoglobulins failed to show any beneficial effect.

Abstract (excerpt)

The best therapy regimen for refractory obstetrical antiphospholipid syndrome remains to be determined. Additional treatments with steroids, plasma exchanges and immunoglobulins failed to show any beneficial effect. We present a case of a…

Excerpt shown for reference under fair use — read the full paper at the publisher.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: CORE · DOI 10.1016/j.autrev.2015.04.010